Biomea Fusion, Inc. ( BMEA) - Key Metrics
BMEA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.12 | -$0.14 | -$0.14 |
| 2026Q1 | $0 | -$0.17 | -$0.16 | -$0.16 |
| 2025Q4 | $0 | $0.06 | -$0.18 | -$0.18 |
| 2025Q3 | $0 | -$0.40 | -$0.30 | -$0.30 |
| 2025Q2 | $0 | -$0.51 | -$0.47 | -$0.47 |
BMEA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.06 |
| 2026Q1 | 0% | -2.25 |
| 2025Q4 | 0% | 4.86 |
| 2025Q3 | 0% | -1.87 |
| 2025Q2 | 0% | -0.88 |
BMEA
Price: $0.87
52 week price:
Earnings Per Share: -0.18 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 55800
Market Capitalization: 91.8 million